FACULTY
Blood Conservation and Chemotherapy-Induced Anemia: From Evidence-Based Guidelines to Clinical Practice
The contents of this issue of Johns Hopkins Advanced Studies in Medicine and University of Tennessee Advanced Studies in Pharmacy include 4 review articles.
Activity Date: September 2008  — Activity Info: Volume 8, (10)
Goals & Objectives | Faculty | Complete Pre-Test Activity | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired)

 

Full Disclosure Policy Affecting CE Activities:
As a provider accredited by the Accreditation Council for Continuing Medical Education, it is the policy of The Johns Hopkins University School of Medicine to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a provider has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Course Directors and Participating Faculty reported the following:

COURSE DIRECTORS

David S. Ettinger, MD, FACP, FCCP
Alex Grass Professor of Oncology
The Sidney Kimmel Comprehensive Cancer Center
The Johns Hopkins University
Baltimore, Maryland
Dr Ettinger reports having no financial or advisory relationships with corporate organizations related to this activity.

Edward J. Norris, MD, MBA, FAHA
Associate Professor
Department of Anesthesiology and Critical Care Medicine
Director, Vascular Anesthesia
The Johns Hopkins University School of Medicine
Baltimore, Maryland
Dr Norris reports having no financial or advisory relationships with corporate organizations related to this activity.

PARTICIPATING FACULTY

Charles L. Bennett, MD, PhD, MPP
Professor
VA Chicago Healthcare System
VA Center for the Management of Complex Chronic Care
Department of Medicine
Division of Hematology/Oncology
The Robert H. Lurie Comprehensive Cancer Center
Northwestern University
Chicago, Illinois
Dr Bennett reports having no financial or advisory relationships with corporate organizations related to this activity.

Lawrence Tim Goodnough, MD
Professor of Pathology and Medicine
Department of Pathology
Stanford University School of Medicine
Stanford, California
Dr Goodnough reports serving as a consultant for, receiving honoraria from, and serving on the speakers’ bureau for American Regent, Inc, Amgen Inc, Ortho Biotech, and Watson Pharmaceuticals, Inc.

Stephen Y. Lai, MD, PhD
Assistant Professor
University of Texas MD Anderson Cancer Center
Departments of Head and Neck Cancer and Molecular and Cellular Oncology
Houston, Texas
Dr Lai reports having no financial or advisory relationships with corporate organizations related to this activity.

George M. Rodgers, III, MD, PhD
Professor, Divisions of Hematology and Oncology
Department of Internal Medicine
Huntsman Cancer Institute at the University of Utah
Salt Lake City, Utah
Dr Rodgers reports receiving grants/research support from, serving as a consultant for, and serving on the speakers’ bureau for Amgen Inc.

Athena T. Samaras, BA
Project Coordinator
VA Chicago Healthcare System
VA Center for the Management of Complex Chronic Care
Department of Medicine
Division of Hematology/Oncology
Northwestern University
Chicago, Illinois
Ms Samaras reports having no financial or advisory relationships with corporate organizations related to this activity.

Aryeh Shander, MD, FCCM, FCCP
Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine
Englewood Hospital and Medical Center
Englewood, New Jersey
Clinical Professor of Anesthesiology, Medicine and Surgery
Mount Sinai School of Medicine
New York, New York
Dr Shander reports receiving grants/research support from Abbott Laboratories, AstraZeneca, Ortho Biotech, and Zymogenetics; serving as a consultant for Bayer, Biopure, HemoConcepts, Inc, Novo Nordisk, Ortho Biotech, and Zymogenetics; and receiving honoraria for serving on the speakers’ bureau for Bayer, Baxter, HemoConcepts, Inc, Novo Nordisk, Ortho Biotech, Pfizer Inc, and Zymogenetics.

This monograph was reviewed by Rowena N. Schwartz, PharmD, BCOP, for the Accreditation Council for Pharmacy Education accreditation purposes.

Notice: The audience is advised that articles in this CE activity may contain reference(s) to unlabeled or unapproved uses of drugs or devices.

Dr Goodnough—iron sucrose injection, USP and sodium ferric gluconate complex in sucrose injection.
Dr Shander—Cell Saver, coagulation factor VIIa (recombinant), erythropoiesis-stimulating agents, and iron.

All other faculty have indicated that they have not referenced unlabeled or unapproved uses of drugs or devices.

Johns Hopkins Advanced Studies in Medicine provides disclosure information from contributing authors, lead presenters, and participating faculty. Johns Hopkins Advanced Studies in Medicine does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

     
Home | Contact Us | View Account | Need Help?